Health Care: Drugs

Amicus Therapeutics Inc (FOLD: NASDAQ)

$15.09 0.2 | 1.34%
09/04/15 - 01:16 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 1.22M 363.00K 18.41M 21.43M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 1.22M 363.00K 18.41M 21.43M
Selling, General, and Administrative Expenses 20.72M 18.89M 19.36M 19.88M
Research & Development 47.62M 41.94M 50.27M 50.86M
Operating Income before D & A (EBITDA) -67.12M -60.47M -51.23M -49.30M
Depreciation & Amortization 1.55M 1.72M 1.70M 1.58M
Interest Income 223.00K 174.00K 316.00K 160.00K
Other Income - Net -77.00K 908.00K 674.00K 2.83M
Special Income / Charges -100.00K 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -68.56M -63.10M -51.94M -47.89M
Interest Expense 1.48M 46.00K 89.00K 148.00K
Pre-Tax Income -70.04M -63.14M -52.03M -48.04M
Income Taxes -1.11M -3.51M -3.24M -3.63M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -68.93M -59.63M -48.78M -44.41M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -68.93M -59.63M -48.78M -44.41M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -68.93M -59.63M -48.78M -44.41M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-68.89M -57.64M -48.78M -44.41M
Preferred Dividends
Net Income Available To Common -68.93M -59.63M -48.78M -44.41M
Basic EPS from Continuing Ops. -0.93 -1.16 -1.07 -1.28
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.93 -1.16 -1.07 -1.28
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.93 -1.16 -1.07 -1.28
Basic Normalized Net Income/Share -0.93 -1.12 -1.07 -1.28
EPS fr Continuing Ops. -0.93 -1.16 -1.07 -1.28
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.93 -1.16 -1.07 -1.28
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.93 -1.16 -1.07 -1.28
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.93 -1.12 -1.07 -1.28
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with FOLD

Latest FOLD Headlines from TheStreet

More Financial News for FOLD

Press Releases for FOLD

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter